articles and announcements

Latest News

April 24, 2017

Stem Cell Research at UConn Health

Stem Cells Help UConn Researchers Identify Defects Causing Angelman syndrome Researchers at UConn Health are using stem cells derived from patients with Angelman syndrome to identify the underlying cellular defects that cause the rare neurogenetic disorder, an important step in […]

Read more
Ovid Therapeutics logo
September 9, 2016

Ovid Therapeutics Receives Orphan Drug Designation

Ovid Therapeutics, a privately held biopharmaceutical company based in New York City, announced that the U.S. Food and Drug Administration has granted orphan drug designation to OV101 for the treatment of patients with Angelman syndrome. See the press release. 

Read more
April 20, 2016

UBE3A’s Role in Seizures

Research has answered some questions about UBE3A’s role in seizures ASF-funded research conducted at Dr. Ben Philpot’s lab at the University of North Carolina-Chapel Hill has answered some questions about UBE3A’s role in seizures in individuals with Angelman syndrome, and […]

Read more
December 8, 2015

Health Issues in Adults with Angelman Syndrome

Research Investigates Health Issues in Adults with Angelman Syndrome Dr. Ron Thibert, the well-known Angelman syndrome clinician and champion of the low-glycemic index dietary seizure treatment, and Dr. Anna Larson, both of Massachusetts General Hospital, published the findings from their clinical […]

Read more
AS Clinic at Mayo Clinic Rochester, MN
November 30, 2015

New Angelman Syndrome Clinic at Mayo Clinic

The ASF Celebrates the Opening of the New Angelman Syndrome Clinic at Mayo Clinic One-Stop Facility Provides Comprehensive Support for Individuals with Angelman syndrome from Infancy through Adulthood ROCHESTER, Minn., November 30, 2015 – Mayo Clinic and the Angelman Syndrome Foundation […]

Read more
Dr. Mark Zylka
August 6, 2015

ASF-funded research at UNC published in Cell

Angelman Syndrome Foundation-Funded Research at University of North Carolina-Chapel Hill Leads to Breakthrough in AS- and Autism-related research Research from the lab of Dr. Mark Zylka, a leading AS researcher and associate professor of cell biology and physiology at the […]

Read more
Dr. Arthur Beaudet
December 1, 2014

Possible Therapeutic for Angelman Syndrome

ASF-Funded Research Discovers Possible Therapeutic for Angelman Syndrome Promising ASF-funded research continues to move closer toward possible clinical trials, as announced today in a paper in Nature by Dr. Art Beaudet and his research team at Baylor College of Medicine. The ASF […]

Read more